Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $2.1 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 30.89% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.9 billion (up 3.41% YoY) and the FY2025 annual result came in at $2.0 billion, down 5.97% from the prior year.
• Liabilities and Shareholders Equity slipped to $2.1 billion in Q2 2026, from $2.1 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.1 billion in Q1 2026 to a low of $1.3 billion in Q2 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 18.52% — and 2024, when it jumped 40.18%.
• Tracing MEDP's Liabilities and Shareholders Equity over 5 years: stood at $1.4 billion in 2022, then gained by 22.5% to $1.7 billion in 2023, then gained by 26.8% to $2.1 billion in 2024, then declined by 5.97% to $2.0 billion in 2025, then increased by 4.14% to $2.1 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.